8-K 1 form8_k.htm FORM 8-K FOR PRESS RELEASE

SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF
 THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported):  March 7, 2017 (March 7, 2017)


CHEMBIO DIAGNOSTICS, INC.
(Exact name of registrant as specified in its charter)
 
Nevada
  
0-30379
  
88-0425691
(State or other jurisdiction
  
(Commission File Number)
  
(IRS Employer
of Incorporation)
      
Identification Number)
   
3661 Horseblock Road
    
   
Medford, NY 11763
    
   
(Address of principal executive offices)
    
   
631-924-1135
    
   
(Registrant's Telephone Number)
    
 
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
 
 


ITEM 7.01.   REGULATION FD DISCLOSURE.


On March 7, 2017, the Company issued a press release entitled "Chembio Diagnostics Reports 2016 Financial Results".   A copy of the press release is furnished herewith as Exhibit 99.1

On March 7, 2017, the Company posted a PowerPoint Presentation to their website entitled "Investor Presentation March, 2017."  A copy of the presentation is furnished herewith as Exhibit 99.2.

In addition, also on March 7, 2017, the Company posted an Investor Fact Sheet to their website.  A copy of the fact sheet is furnished herewith as Exhibit 99.3

The information in this Item 7.01 of this Form 8-K is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that section. The information in this Item 7.01 of this Form 8-K also shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.


ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

Exhibit Number
Description
99.1
Press Release entitled "Chembio Diagnostics Reports 2016  Financial Results" dated March 7, 2017
99.2
Presentation entitled "Investor Presentation March 2017" dated  March 7, 2017
99.3
Investor Fact Sheet posted to the company website dated March 7, 2017
 
 
 
 


  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


March 7, 2017               Chembio Diagnostics, Inc.




By:    /s/ John J. Sperzel III                                      
John J. Sperzel III
Chief Executive Officer
 
EXHIBIT INDEX
Exhibit Number
Description
99.1
Press Release entitled "Chembio Diagnostics Reports 2016 Financial Results" dated March 7, 2017
99.2
Presentation entitled "Investor Presentation March, 2017" dated  March 7, 2017
99.3
Investor Fact Sheet posted to the company website dated March 7, 2017